Skip to content

OrthoPediatrics KIDS Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction

Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction at other companies

3D Systems logo
3D SystemsDDD
$332K
Carlsmed, Inc. Common Stock logo
Carlsmed, Inc. Common StockCARL
$0-100%

Other financials

Income statement

See full
Revenue$59.4M+13.3%
Gross profit$43.4M+13.4%
Operating income-$8.3M+24.1%
Net income-$10.7M-0.3%
EPS (diluted)-$0.45+2.2%

Balance sheet

See full
Cash & equivalents$14.2M-59.8%
Total debt$5.4M+271%
Total equity$338.7M-2.4%
Total assets$502.2M+6.8%

Cash flow

See full
Operating cash flow-$3.3M+20.9%
CapEx$1.8M-58.4%
Free cash flow-$5.0M+39.8%

Valuation

See full
Market cap$503.94M+0.3%
Enterprise value$495.11M+5.7%
P/S2.1×-0.3×

Profitability

See full
Gross margin73.1%+0.3pp
Operating margin-15%-1.6pp
Net margin-16.3%-2.1pp
FCF margin-12.9%-4.3pp

Returns & leverage

See full
Return on equity-11.6%+0.2pp
Debt / equity0.0×
Current ratio5.2×-1.0×

Where this comes from

Reported directly by OrthoPediatrics in its filing.

Tagged under the XBRL concept us-gaap:DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction.

The official record: OrthoPediatrics’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about OrthoPediatrics's debt issuance costs incurred during noncash or partial noncash transaction.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OrthoPediatrics's debt issuance costs incurred during noncash or partial noncash transaction?
OrthoPediatrics (KIDS) reported debt issuance costs incurred during noncash or partial noncash transaction of $289K in Q1 2026.
What does debt issuance costs incurred during noncash or partial noncash transaction mean?
Records the non-cash portion of costs associated with securing debt financing, such as legal, underwriting, or registration fees that are not settled in cash. This metric highlights the hidden costs of capital raising activities that do not immediately impact cash balances. Monitoring these costs helps in evaluating the total effective cost of debt financing arrangements.